|
Volumn 21, Issue 5, 2004, Pages 679-690
|
Assuring quality and performance of sustained and controlled release parenterals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABARELIX;
AMBELCET;
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
BETAMETHASONE;
BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE;
BIOPOLYMER;
CARMUSTINE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
GOSERELIN;
HUMAN GROWTH HORMONE;
INSULIN;
ISOPHANE INSULIN;
LEUPRORELIN;
LEVONORGESTREL;
LIPOSOME;
MEDROXYPROGESTERONE ACETATE;
METHYLPREDNISOLONE;
METHYLPREDNISOLONE ACETATE;
MICROSPHERE;
OCTREOTIDE;
TRELSTAR DEPOT;
TRIPTORELIN;
UNCLASSIFIED DRUG;
ARTICLE;
BIOEQUIVALENCE;
CONTROLLED RELEASE FORMULATION;
DEVICE;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG SOLUBILITY;
DRUG STABILITY;
EMULSION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INJECTION;
NEEDLE;
NONHUMAN;
PARTICLE SIZE;
PERFORMANCE;
PRIORITY JOURNAL;
QUALITY CONTROL;
SUSTAINED RELEASE PREPARATION;
SYRINGE;
|
EID: 1842555130
PISSN: 09280987
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejps.2004.03.001 Document Type: Conference Paper |
Times cited : (58)
|
References (1)
|